Rationale and Design of the KYOTO HEART Study: Effects of Valsartan on Morbidity and Mortality in Uncontrolled Hypertensive Patients With High Risk of Cardiovascular Events

Journal of Human Hypertension - United Kingdom
doi 10.1038/jhh.2008.116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients: Rationale, Design, and Methods

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2003English

A Study to Assess the Effects of a Broad-Spectrum Immune Modulatory Therapy on Mortality and Morbidity in Patients With Chronic Heart Failure: The ACCLAIM Trial Rationale and Design

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Types of Sedentary Behavior and Risk of Cardiovascular Events and Mortality in Blacks: The Jackson Heart Study

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Hypertriglyceridemia Is Associated With Long-Term Risk of Cardiovascular Events and Specific Comorbidity in Very High-Risk Hypertensive Patients

Ukrainian Biochemical Journal
Biochemistry
2020English

Risk of Cardiovascular Morbidity and Mortality in Relation to Temperature

Online Journal of Public Health Informatics
2013English

Effects of Aliskiren on Mortality, Cardiovascular Outcomes and Adverse Events in Patients With Diabetes and Cardiovascular Disease or Risk: A Systematic Review and Meta-Analysis of 13,395 Patients

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2017English

Association of Masked Uncontrolled Hypertension and Cardiovascular Diseases in Treated Hypertensive Patients

Archives of Medical Science
Medicine
2019English

Rationale and Design of a Study to Evaluate Management of Proteinuria in Patients at High Risk for Vascular Events: The IMPROVE Trial

Journal of Human Hypertension
Internal Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy